International Journal of Clinical Case Reports 2024, Vol.14, No.4, 189-201 http://medscipublisher.com/index.php/ijccr 201 Mysler S.J., Perazzo F., and Mandó P., 2023, Autoimmune encephalitis related to nivolumab followed by tumor regression, Medicina, 83(3): 479-483. PMID: 37379548 Rappold P., Silagy A., Kotecha R., and Hakimi A., 2021, Immune checkpoint blockade in renal cell carcinoma, Journal of Surgical Oncology, 123: 739-750. https://doi.org/10.1002/jso.26339 PMID: 33595892 PMCID: PMC8364550 Vuong L., Kotecha R., Voss M., and Hakimi A., 2019, Tumor microenvironment dynamics in clear-cell renal cell carcinoma, Cancer Discovery, 9(10): 1349-1357. https://doi.org/10.1158/2159-8290.CD-19-0499 PMID: 31527133 PMCID: PMC6774890 Xu W., Atkins M., and McDermott D., 2020, Checkpoint inhibitor immunotherapy in kidney cancer, Nature Reviews Urology, 17: 137-150. https://doi.org/10.1038/s41585-020-0282-3 PMID: 32020040 Zhou J.Y., 2024, The Application of genomics in personalized cancer therapy, Cancer Genetics and Epigenetics, 12(1): 66-74. https://doi.org/10.5376/cge.2024.12.0009
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==